肿瘤预防与治疗
腫瘤預防與治療
종류예방여치료
JOURNAL OF CANCER CONTROL AND TREATMENT
2014年
4期
171-175
,共5页
曹兰青%李卉%刘莉%王琼%李冬锋%齐亚娜%李卉%李佳圆
曹蘭青%李卉%劉莉%王瓊%李鼕鋒%齊亞娜%李卉%李佳圓
조란청%리훼%류리%왕경%리동봉%제아나%리훼%리가원
乳腺肿瘤%雌激素受体α%多态性,单核苷酸
乳腺腫瘤%雌激素受體α%多態性,單覈苷痠
유선종류%자격소수체α%다태성,단핵감산
Breast Neoplasms%Estrogen Receptor Alpha%Polymorphism%Single Nucleotide
目的:探讨雌激素受体XbaⅠ、PvuⅡ基因多态性与四川汉族女性乳腺癌患病风险的关系。方法:采用病例对照研究设计,序贯收集乳腺癌病例221例,健康对照252例。采用问卷调查收集一般人口学特征、身高、体重、生殖生育史、雌激素药物服用史等信息;采用限制性片段长度多态性技术,检测ERα基因XbaⅠ( rs9340799) A/G(x/X)、PvuⅡ(rs2234693)C/T(P/p)基因突变情况。采用非条件多因素Logistic回归模型分析XbaⅠ、PvuⅡ基因多态性的独立效应及联合效应。按绝经状态进行亚组分析。结果:在总人群及不同绝经状态亚组中,XbaⅠ、PvuⅡ基因型分布与乳腺癌患病风险无统计学关联( P>0.05)。以xxPP野生基因型组合做参照,在总人群中,只携带X等位基因能明显降低乳腺癌患病风险(OR=0.31,95%CI:0.11~0.90),该效应与X、p等位基因联合暴露效应接近(OR=0.39,95%CI:0.15~1.00)。在绝经前女性中,上述暴露组合效应分别为0.12(0.03~0.54)和0.25(0.07~0.89)。结论:雌激素受体 XbaⅠX等位基因可能对乳腺癌患病风险具有保护效应。
目的:探討雌激素受體XbaⅠ、PvuⅡ基因多態性與四川漢族女性乳腺癌患病風險的關繫。方法:採用病例對照研究設計,序貫收集乳腺癌病例221例,健康對照252例。採用問捲調查收集一般人口學特徵、身高、體重、生殖生育史、雌激素藥物服用史等信息;採用限製性片段長度多態性技術,檢測ERα基因XbaⅠ( rs9340799) A/G(x/X)、PvuⅡ(rs2234693)C/T(P/p)基因突變情況。採用非條件多因素Logistic迴歸模型分析XbaⅠ、PvuⅡ基因多態性的獨立效應及聯閤效應。按絕經狀態進行亞組分析。結果:在總人群及不同絕經狀態亞組中,XbaⅠ、PvuⅡ基因型分佈與乳腺癌患病風險無統計學關聯( P>0.05)。以xxPP野生基因型組閤做參照,在總人群中,隻攜帶X等位基因能明顯降低乳腺癌患病風險(OR=0.31,95%CI:0.11~0.90),該效應與X、p等位基因聯閤暴露效應接近(OR=0.39,95%CI:0.15~1.00)。在絕經前女性中,上述暴露組閤效應分彆為0.12(0.03~0.54)和0.25(0.07~0.89)。結論:雌激素受體 XbaⅠX等位基因可能對乳腺癌患病風險具有保護效應。
목적:탐토자격소수체XbaⅠ、PvuⅡ기인다태성여사천한족녀성유선암환병풍험적관계。방법:채용병례대조연구설계,서관수집유선암병례221례,건강대조252례。채용문권조사수집일반인구학특정、신고、체중、생식생육사、자격소약물복용사등신식;채용한제성편단장도다태성기술,검측ERα기인XbaⅠ( rs9340799) A/G(x/X)、PvuⅡ(rs2234693)C/T(P/p)기인돌변정황。채용비조건다인소Logistic회귀모형분석XbaⅠ、PvuⅡ기인다태성적독립효응급연합효응。안절경상태진행아조분석。결과:재총인군급불동절경상태아조중,XbaⅠ、PvuⅡ기인형분포여유선암환병풍험무통계학관련( P>0.05)。이xxPP야생기인형조합주삼조,재총인군중,지휴대X등위기인능명현강저유선암환병풍험(OR=0.31,95%CI:0.11~0.90),해효응여X、p등위기인연합폭로효응접근(OR=0.39,95%CI:0.15~1.00)。재절경전녀성중,상술폭로조합효응분별위0.12(0.03~0.54)화0.25(0.07~0.89)。결론:자격소수체 XbaⅠX등위기인가능대유선암환병풍험구유보호효응。
Objective: To explore the association between XbaⅠand PvuⅡgene polymorphism of ERαand breast cancer risk among females in Sichuan province. Methods: A case-control study was designed. A total of 221 cases of breast cancer and 252 controls were sequentially collected. Questionnaires were used to obtain the factors including demo-graphic characteristics, height, weight, history of reproduction, and estrogen taking history. Restricted fragment length pol-ymorphisms were used to examine XbaⅠ(rs9340799) A/G (x/X), PvuⅡ(rs2234693) C/T (P/p) of ERα. Uncondi-tional logistic regression model was used to evaluate the single and combined effects of XbaⅠ, PvuⅡ gene polymorphism on breast cancer risk. Subgroup analysis on menopausal status was also performed. Results: Significantly association be-tween XbaⅠ, PvuⅡ gene polymorphism and breast cancer was observed among neither total group nor subgroups ( P>0. 05). Conferring to xxPP genotype carriers, for general females, carrying X mutate alleles had lower breast cancer risk (OR=0. 31,95%CI:0. 11-0. 90),which was closed to the effect of co-exposure of X and p allele (OR=0. 39,95%CI:0. 15-1. 00). In premenopausal women, the effect of the exposure modalities above were 0. 12(0. 03-0. 54)and 0. 25 (0. 07-0. 89) respectively. Conclusions:Carrying X allele of XbaⅠmay decrease the risk of breast cancer.